Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles.

dc.contributor.authorOmwoyo, Wesley
dc.contributor.authorMelariri, Paula
dc.contributor.authorGathirwa, Jeremiah
dc.contributor.authorOloo, Florence
dc.contributor.authorMahanga, Geoffrey
dc.contributor.authorKalombo, Lonji
dc.contributor.authorOgutu, Bernhards
dc.contributor.authorSwai, Hulda
dc.date.accessioned2019-10-16T09:00:19Z
dc.date.available2019-10-16T09:00:19Z
dc.date.issued2016-04-01
dc.descriptionResearch Article published by Elsevier Volume 12, Issue 3, April 2016en_US
dc.description.abstractEffective use of dihydroartemisinin (DHA) is limited by poor water-solubility, poor pharmacokinetic profile and unsatisfactory clinical outcome especially in monotherapy. To reduce such limitations, we reformulated DHA into solid lipid nanoparticles (SLNs) as a nanomedicine drug delivery system. DHA-SLNs were characterized for physical parameters and evaluated for in vitro and in vivo antimalarial efficacy. DHA-SLNs showed desirable particle characteristics including particle size (240.7 nm), particle surface charge (+ 17.0 mV), drug loadings (13.9 wt %), encapsulation efficacy (62.3%), polydispersity index (0.16) and a spherical appearance. Storage stability up to 90 days and sustained release of drug over 20 h was achieved. Enhanced in vitro (IC50 0.25 ng/ml) and in vivo (97.24% chemosuppression at 2 mg/kg/day) antimalarial activity was observed. Enhancement in efficacy was 24% when compared to free DHA. These encouraging results show potential of using the described formulation for DHA drug delivery for clinical application.en_US
dc.identifier.other26724538
dc.identifier.urihttps://doi.org/10.1016/j.nano.2015.11.017
dc.identifier.urihttp://dspace.nm-aist.ac.tz/handle/123456789/492
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectDihydroartemisininen_US
dc.subjectNanomedicine drug deliveryen_US
dc.subjectSolid lipid nanoparticlesen_US
dc.titleDevelopment, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles.en_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
JA_LiSBE_Abstract_2016.pdf
Size:
5.68 KB
Format:
Adobe Portable Document Format
Description:
Abstract

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2 KB
Format:
Item-specific license agreed upon to submission
Description: